Novogen (ASX: NRT, NASDAQ: NVGN) is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. Headquartered in Sydney, Australia, Novogen collaborates with leading scientists, clinicians, and investors around the world.

  • News


    More News

  • Upcoming Events

    23-24 March 2017

    Hong Kong Biotech Invest

    KPMG Hong Kong Central, Hong Kong

    30 March 2017

    Broker meets Biotech, Perth

    Parmelia Hilton, 14 Mill Street, Perth

    11 April 2017

    Proactive Investors Spotlight CEO sessions

    CQ Functions, 113 Queen Street, Melbourne

    16 May 2017

    ASX CEO Sessions

    ASX Auditorium, 18 Bridge St, Sydney

    More Events